Stemedica
  • About Us
    • Company Overview
    • Board of Directors
    • Management Team
  • Technology
    • Manufacturing
    • Our Progenitor Cells
    • Intellectual Property
  • Clinical
    • Clinical Pipeline
    • Clinical Trial Activities
      • Ischemic Stroke
      • Alzheimer’s Disease
    • R&D
  • Media
    • Press Releases
    • Publications
  • Contact
Select Page

Stemedica Obtains an Exclusive Worldwide License for Stem Cell Stabilization and Preservation Technologies

by stemedica admin | Mar 24, 2015 | Partnerships

Commercial-scale Preservation of Therapeutically-active Stem Cell-derived Products For Worldwide Marketplace Opportunities  SAN DIEGO—March 24, 2015—Stemedica Cell Technologies Inc., (Stemedica), announced today that Universal Stabilization Technologies (UST) has...

Stemedica Enters into a Global Distribution Agreement with Life Technologies

by stemedica admin | Jun 13, 2013 | Partnerships

Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and clinical development, announced today they have entered into a Global Distribution Agreement with Life Technologies Corporation. Under the terms of this agreement,...

Categories

  • Clinical Trials
  • Company Initiatives
  • Intellectual Property
  • Manufacturing
  • Partnerships
  • Publications
  • Subsidiaries

Copyright © 2007-2020 Stemedica Cell Technologies, Inc. All rights reserved.
6350 Nancy Ridge Drive, Suite 106, San Diego CA 92121 +1 858 658 0910

Privacy Policy